Search

everythinglearnresearchcommunity

for

Search:↓

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

Hemp's compounds can be used in natural insecticides, cosmetics, and food supplements.

α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.

Exosomes could be key in treating skin conditions and healing wounds.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

New ginseng compounds may help treat degenerative diseases.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Platelet-rich plasma may help heal injuries.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

These medications for BPH have known risks and may have new side effects.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

These medications for BPH have known risks and may have new side effects.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.